Takeda and Cognition Kit partner in study to pilot wearable software in patients with Major Depressive Disorder (MDD)

CAMBRIDGE, England and DEERFIELD, Ill., Feb. 23, 2017 /PRNewswire/ — Takeda Pharmaceuticals U.S.A., Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502) and Cognition Kit Limited, a joint venture between Cambridge Cognition Holdings PLC and Ctrl Group Limited, announc

Most Popular

To Top